Advertisement
UK markets close in 6 hours 41 minutes
  • FTSE 100

    8,081.24
    +36.43 (+0.45%)
     
  • FTSE 250

    19,796.73
    -2.99 (-0.02%)
     
  • AIM

    755.52
    +0.65 (+0.09%)
     
  • GBP/EUR

    1.1632
    +0.0004 (+0.03%)
     
  • GBP/USD

    1.2425
    -0.0027 (-0.22%)
     
  • Bitcoin GBP

    53,623.45
    +368.13 (+0.69%)
     
  • CMC Crypto 200

    1,438.69
    +14.59 (+1.02%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CRUDE OIL

    82.96
    -0.40 (-0.48%)
     
  • GOLD FUTURES

    2,331.40
    -10.70 (-0.46%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • DAX

    18,199.09
    +61.44 (+0.34%)
     
  • CAC 40

    8,121.36
    +15.58 (+0.19%)
     

Novavax Downgraded by JPMorgan Chase. Time to Sell?

Novavax Downgraded by JPMorgan Chase. Time to Sell?

The Novavax (NASDAQ: NVAX) rollercoaster has been a wild one. The stock soared more than 2,700% in 2020 after the company received $1.6 billion from the U.S. government to develop the COVID-19 vaccine we now know as Nuvaxovid. Unfortunately, Novavax didn't receive authorization to sell its vaccine in the U.S. until this July.